https://www.selleckchem.com/pr....oducts/rxdx-106-cep-
Currently, 3 AONS are approved. Whether dystrophin levels are sufficient to slowdown disease progression needs to be confirmed. Enhancing AON uptake by muscles is currently under investigation. Gene editing is an alternative, but one that involves practical and ethical concerns. Given the field's momentum, we believe the efficiency of frame-restoring approaches will improve.The Internet widely display interactions between various parties, calling for research to understand how message- and source-related factors in these easi
Like
Comment
Share
